1. Home
  2. COTY vs EXAS Comparison

COTY vs EXAS Comparison

Compare COTY & EXAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Coty Inc.

COTY

Coty Inc.

HOLD

Current Price

$3.26

Market Cap

2.9B

ML Signal

HOLD

Logo Exact Sciences Corporation

EXAS

Exact Sciences Corporation

HOLD

Current Price

$101.43

Market Cap

11.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
COTY
EXAS
Founded
1904
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Package Goods/Cosmetics
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.9B
11.0B
IPO Year
2013
N/A

Fundamental Metrics

Financial Performance
Metric
COTY
EXAS
Price
$3.26
$101.43
Analyst Decision
Hold
Buy
Analyst Count
18
20
Target Price
$5.34
$77.94
AVG Volume (30 Days)
5.6M
10.3M
Earning Date
11-05-2025
11-03-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$5,798,600,000.00
$3,082,033,000.00
Revenue This Year
$1.90
$19.40
Revenue Next Year
$2.53
$13.51
P/E Ratio
N/A
N/A
Revenue Growth
N/A
14.47
52 Week Low
$3.12
$38.81
52 Week High
$7.71
$101.95

Technical Indicators

Market Signals
Indicator
COTY
EXAS
Relative Strength Index (RSI) 41.60 86.91
Support Level $3.24 $101.35
Resistance Level $3.42 $101.93
Average True Range (ATR) 0.11 0.36
MACD 0.02 -1.35
Stochastic Oscillator 27.54 43.00

Price Performance

Historical Comparison
COTY
EXAS

About COTY Coty Inc.

Coty is a global beauty maker that generates 65% of sales from prestige beauty products (primarily fragrances) and 35% from mass makeup, skin care, and fragrance. For the fragrance business, Coty licenses luxury and high-end brands including Gucci, Burberry, Hugo Boss, Davidoff, and Calvin Klein. In contrast, its consumer cosmetics business focuses on acquired mass brands such as CoverGirl, Max Factor, Rimmel, Sally Hansen, and Bourjois. It also collaborates with social media celebrity Kylie Jenner to manage makeup products bearing her name. By region, Coty generates close to 48% of sales from Europe, 40% from the Americas, and 12% from Asia-Pacific. German investment firm JAB is a controlling shareholder, with a 54% stake.

About EXAS Exact Sciences Corporation

Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It also has a pipeline of blood-based tests for molecular residual disease, colorectal cancer screening, and multicancer screening.

Share on Social Networks: